With additional dual CD31‒desmin immunolabeling, we found more foci of VI than by H&E staining in the present study and dual CD31-desmin immunolabeling could more stratify for patients with surgically resected pancreatic cancers. The gene discussed is DES; the disease is familial pancreatic carcinoma.